Natale Isabella, Harvey Craig, Wood Pene, Anderson Karen
Drugs and Alcohol Services, Barwon Health, Geelong.
La Trobe University, Bendigo, Australia.
Qual Res Med Healthc. 2023 Jul 19;7(2):10868. doi: 10.4081/qrmh.2023.10868.
Engagement in take-home naloxone (THN) programs by people receiving opioid substitution treatment (OST) in Australia is low despite methadone being a significant contributor to opioid overdose deaths. Our aim was to explore barriers and facilitators for OST patients to engage in THN. We used a descriptive qualitative design with thematic analysis to gain insight into naloxone uptake by people engaged in an OST program in regional Australia. Eleven participants were interviewed; eight had previously engaged with THN. Barriers to THN included limited knowledge and understanding, lack of information, and not personally experiencing an overdose. Facilitators included having a traumatic experience of overdose, knowledge and understanding of THN and overdose, empowerment in carrying naloxone, and expanding THN programs. Support for the expansion of THN programs is desired among participants, and widespread peer distribution is understood to be the key to success. This study found that prior traumatic experience of overdose facilitates acceptance of THN, and being offered THN was the most important factor in engagement. Less clear is how to engage people who lack a traumatic overdose experience.
尽管美沙酮是阿片类药物过量死亡的一个重要因素，但在澳大利亚接受阿片类药物替代治疗（OST）的人群参与带回家纳洛酮（THN）项目的比例较低。我们的目的是探讨OST患者参与THN的障碍和促进因素。我们采用描述性定性设计和主题分析，以深入了解澳大利亚地区参与OST项目的人群对纳洛酮的接受情况。采访了11名参与者；其中8人之前参与过THN。THN的障碍包括知识和理解有限、信息缺乏以及没有亲身经历过过量用药。促进因素包括有过量用药的创伤经历、对THN和过量用药的知识和理解、携带纳洛酮的自主权以及扩大THN项目。参与者希望扩大THN项目，并且广泛的同伴分发被认为是成功的关键。这项研究发现，之前过量用药的创伤经历有助于接受THN，而提供THN是参与的最重要因素。对于如何让那些没有过量用药创伤经历的人参与进来，还不太清楚。
